moscow < most < mostly

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 108.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000015 (2013)	Jörg Kaufmann [Allemagne] ; Eugen Feist [Allemagne] ; Anne-Eve Roske [Allemagne] ; Wolfgang A. Schmidt [Allemagne]	Monotherapy with tocilizumab or TNF-alpha inhibitors in patients with rheumatoid arthritis: efficacy, treatment satisfaction, and persistence in routine clinical practice
000025 (2014)	Shuji Ohta [Japon] ; Tomomi Tsuru [Japon] ; Kimio Terao [Japon] ; Seiji Mogi [Japon] ; Midori Suzaki [Japon] ; Eisuke Shono [Japon] ; Yoshimasa Ishida [Japon] ; Eriko Tarumi [Japon] ; Masato Imai [Japon]	Mechanism‐based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)
000049 (2012)	Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]	Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
000068 (2012)	Yee Chiu [Royaume-Uni] ; Andrew J. K. Ostor [Royaume-Uni] ; Anthony Hammond [Royaume-Uni] ; Katharina Sokoll [Royaume-Uni] ; Marina Anderson [Royaume-Uni] ; Maya Buch [Royaume-Uni] ; Michael R. Ehrenstein [Royaume-Uni] ; Patrick Gordon [Royaume-Uni] ; Sophia Steer [Royaume-Uni] ; Ian N. Bruce [Royaume-Uni]	Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales
000075 (2011)	J. D. Alves [Portugal] ; A. Marinho [Portugal] ; M. J. Serra [Portugal]	Tocilizumab: is there life beyond anti‐TNF blockade?
000091 (2012)	Sooha Kim [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni]	Interleukin-6 and cytochrome-P450, reason for concern?
000099 (2010)	Chi Chiu Mok [Hong Kong] ; Lai Shan Tam [Hong Kong] ; Tak Hin Chan [Hong Kong] ; Gavin K. W. Lee [Hong Kong] ; Edmund K. M. Li [Hong Kong]	Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology
000100 (2012)	K. Tenbrock [Allemagne]	Therapie der juvenilen idiopathischen Arthritis (JIA)
000101 (2012)	K. Krüger [Allemagne]	Medikamentöse Interaktionen in der Rheumatologie
000141 (2011)	H. Bastian [Allemagne] ; E. Feist [Allemagne] ; G.-R. Burmester [Allemagne]	Therapiestrategien bei rheumatoider Arthritis
000144 (2012)	U. Lange [Allemagne] ; U. Müller-Ladner [Allemagne]	Potenzielle rheumatologische Medikamentenwechselwirkungen im Alter
000146 (2010)	G. Horneff [Allemagne]	Juvenile Arthritiden
000147 (2010)	Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Hiromi Hagiwara [Japon] ; Akihiro Narita [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Tatsuya Atsumi [Japon] ; Hiroki Shirato [Japon] ; Satoshi Terae [Japon]	Monitoring anti-interleukin 6 receptor antibody treatment for rheumatoid arthritis by quantitative magnetic resonance imaging of the hand and power Doppler ultrasonography of the finger
000166 (2013)	J. Wollenhaupt [Allemagne] ; K. Albrecht [Allemagne] ; K. Krüger [Allemagne] ; U. Müller-Ladner [Allemagne]	The new 2012 German recommendations for treating rheumatoid arthritis
000174 (2012)	M. Gaubitz [Allemagne]	Biologika 2012
000196 (2008)	Y. Shirota [États-Unis] ; Gg Illei [États-Unis] ; Np Nikolov [États-Unis]	Biologic treatments for systemic rheumatic diseases
000203 (2011)	K. Krüger [Allemagne]	Kombinationsbehandlung von Methotrexat mit DMARDs oder Biologika – Aktueller Stand
000206 (2012)	K. Krüger [Allemagne] ; J. Sieper [Allemagne]	Off-Label-Therapie bei rheumatoider Arthritis und Spondyloarthritiden
000212 (2013)	Pierre Gangloff	Biothérapie et odontologie
000223 (2010)	J. Möller [Allemagne] ; H. J. Girschick [Allemagne] ; G. Hahn [Allemagne] ; F. Pessler [Allemagne]	Kortikosteroid-induzierte spinale epidurale Lipomatose bei pädiatrischen Patienten
000234 (2012)	G. Lippi [Italie] ; G. Targher [Italie]	Optimal therapy for reduction of lipoprotein(a)

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "most" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "most" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    most
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021